Understanding hepatopancreatobiliary cancer risks in a population-based primary sclerosing cholangitis-inflammatory bowel disease cohort
Leung KK, Li W, Hansen B, Gulamhusein A, Lapointe-Shaw L, Ricciuto A, Benchimol EI, Flemming JA, Hirschfield GM. Hepatology. 2026; Feb 4 [Epub ahead of print].